Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SANUWAVE Health (SNWV) EBIT Margin (2016 - 2026)

SANUWAVE Health has reported EBIT Margin over the past 17 years, most recently at 11.69% for Q1 2026.

  • Quarterly EBIT Margin fell 1812.0% to 11.69% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 7.26% through Mar 2026, down 861.0% year-over-year, with the annual reading at 11.23% for FY2025, 57.0% down from the prior year.
  • EBIT Margin was 11.69% for Q1 2026 at SANUWAVE Health, down from 14.95% in the prior quarter.
  • Over five years, EBIT Margin peaked at 23.0% in Q2 2024 and troughed at 78.52% in Q2 2022.
  • The 5-year median for EBIT Margin is 6.44% (2025), against an average of 11.3%.
  • The largest YoY upside for EBIT Margin was 17476bps in 2022 against a maximum downside of -17030bps in 2022.
  • A 5-year view of EBIT Margin shows it stood at 28.11% in 2022, then skyrocketed by 153bps to 14.86% in 2023, then soared by 31bps to 19.48% in 2024, then dropped by -23bps to 14.95% in 2025, then crashed by -178bps to 11.69% in 2026.
  • Per Business Quant, the three most recent readings for SNWV's EBIT Margin are 11.69% (Q1 2026), 14.95% (Q4 2025), and 8.01% (Q3 2025).